Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akifumi Ogawa

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Diabetes and Its Complications|June 11, 2022
Discordance in the reduction rate between glycated albumin and glycated hemoglobin levels in type 2 diabetes patients receiving SGLT2 inhibitorsNaoya Shimizu, Akifumi Ogawa, Akinori Hayashi, et al.
Journal of Diabetes and Its Complications|September 12, 2016
Distinct biomarker roles for HbA<sub>1c</sub> and glycated albumin in patients with type 2 diabetes on hemodialysisAkinori Hayashi, Koji Takano, Tsuguto Masaki, et al.
Plos One|October 3, 2012
New indices for predicting glycaemic variabilityAkifumi Ogawa, Akinori Hayashi, Eriko Kishihara, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2011
A woman with salt-wasting congenital adrenal hyperplasia presenting with a mucinous ovarian cystadenoma during pregnancyYuji Kamata, Akinori Hayashi, Akifumi Ogawa, et al.
Scientific Reports|May 24, 2016
Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort studyShoma Chida, Yoshikuni Fujita, Akifumi Ogawa, et al.
Scientific Reports|August 17, 2017
Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptideKazumi Fujimoto, Akinori Hayashi, Yoshio Kodera, et al.
Diabetes Care|May 28, 2021
Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and HypoglycemiaAkinori Hayashi, Naoya Shimizu, Agena Suzuki, et al.
Plos One|October 8, 2013
Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulatorKazumi Fujimoto, Akinori Hayashi, Yuji Kamata, et al.
Clinical Case Reports|March 14, 2015
A very rare case of primary meningococcal arthritis in an adult maleShin Nihonyanagi, Keisuke Sunakawa, Longzhu Cui, et al.
Peptides|July 27, 2014
Physiological fluctuations of human plasma total salusin-β, an endogenous parasympathomimetic/proatherosclerotic peptideAkifumi Ogawa, Kazumi Fujimoto, Akinori Hayashi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Diabetes and Its Complications|June 11, 2022
Discordance in the reduction rate between glycated albumin and glycated hemoglobin levels in type 2 diabetes patients receiving SGLT2 inhibitorsNaoya Shimizu, Akifumi Ogawa, Akinori Hayashi, et al.
Journal of Diabetes and Its Complications|September 12, 2016
Distinct biomarker roles for HbA<sub>1c</sub> and glycated albumin in patients with type 2 diabetes on hemodialysisAkinori Hayashi, Koji Takano, Tsuguto Masaki, et al.
Plos One|October 3, 2012
New indices for predicting glycaemic variabilityAkifumi Ogawa, Akinori Hayashi, Eriko Kishihara, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2011
A woman with salt-wasting congenital adrenal hyperplasia presenting with a mucinous ovarian cystadenoma during pregnancyYuji Kamata, Akinori Hayashi, Akifumi Ogawa, et al.
Scientific Reports|May 24, 2016
Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort studyShoma Chida, Yoshikuni Fujita, Akifumi Ogawa, et al.
Scientific Reports|August 17, 2017
Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptideKazumi Fujimoto, Akinori Hayashi, Yoshio Kodera, et al.
Diabetes Care|May 28, 2021
Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and HypoglycemiaAkinori Hayashi, Naoya Shimizu, Agena Suzuki, et al.
Plos One|October 8, 2013
Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulatorKazumi Fujimoto, Akinori Hayashi, Yuji Kamata, et al.
Clinical Case Reports|March 14, 2015
A very rare case of primary meningococcal arthritis in an adult maleShin Nihonyanagi, Keisuke Sunakawa, Longzhu Cui, et al.
Peptides|July 27, 2014
Physiological fluctuations of human plasma total salusin-β, an endogenous parasympathomimetic/proatherosclerotic peptideAkifumi Ogawa, Kazumi Fujimoto, Akinori Hayashi, et al.
Pageof 1